期刊文献+

脂蛋白磷脂酶A2与急性脑梗死及颈动脉斑块稳定性的关系 被引量:9

Relationship of lipoprotein-associated phospholipase A2 with acute cerebral infraction and stability of carotid artery plaque
原文传递
导出
摘要 目的探讨脂蛋白磷脂酶A2(Lp-PLA2)与急性脑梗死(ACI)及颈动脉斑块稳定性的关系。方法采用化学发光免疫分析技术检测94例ACI患者(ACI组)和49例健康体检者(对照组)的血浆Lp-PLA2水平。并根据颈动脉彩色多普勒超声检查结果,分析ACI组颈动脉斑块与Lp-PLA2水平的关系。结果 ACI组血浆Lp-PLA2水平高于对照组(P<0.01)。ACI组中,颈动脉无斑块组、稳定斑块组和不稳定斑块组的Lp-PLA2水平依次升高(P<0.01),且无斑块组与有斑块组Lp-PLA2水平差异亦有统计学意义(P<0.01)。结论 Lp-PLA2可能是ACI的独立危险因素之一,通过监测Lp-PLA2水平可以间接了解颈动脉斑块的稳定性。 Objective To investigate the relationship of lipoprotein-associated phospholipase A2 (Lp-PLA2) with acute cerebral infraction(ACI) and stability of carotid artery plaque. Methods The level of plasma Lp-PLA2 was detected by chemiluminescence immunoassay in 94 patients with ACI (ACI group) and 49 healthy people(control group). Then according to the result of carotid artery color Doppler ultrasound, the relationship of carotid artery plaque and level of plasma Lp-PLA2 was analyzed. Results The level of plasma Lp-PLA2 in ACI group was significantly higher than that in control group(P〈0. 01). The increase in level of plasma Lp-PLA2 was in an order of unstable plaque group〉 stable plaque group 〉 non-plaque group (P〈0. 01 ). Meanwhile, there was statistical difference in the level of plasma Lp-PLA2 between non-plaque and plaque groups (P〈0. 01 ). Conclusion Lp-PLA2 may be, one of the independent risk factors for ACI, and the stability of carotid artery plaque can be indirectly monitored through detecting the level of plasma LIyPLA2.
出处 《江苏医药》 CAS 2016年第22期2467-2469,共3页 Jiangsu Medical Journal
关键词 脂蛋白磷脂酶A2 动脉粥样硬化 急性脑梗死 颈动脉斑块 Lipoprotein-associated phospholipase A2 Atherosclerosis Acute cerebral infraction Carotid plaques
  • 相关文献

参考文献8

二级参考文献89

  • 1张微微,周小英,黄勇华.不同类型脑梗死患者血清C-反应蛋白的检测及临床意义[J].中华检验医学杂志,2004,27(11):781-783. 被引量:35
  • 2刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 3马梅,刘克强,齐新,何丽华,张东玲,孟东.脂蛋白相关磷脂酶A_2对冠心病患者诊断的临床意义研究[J].中国分子心脏病学杂志,2007,7(3):159-163. 被引量:3
  • 4Grouse JR, Harpold GH, Kahl FR, et al. Evaluation of a scoring system for extracranial carotid atherosclerosis extent with B-mode ultrasound[J]. Stroke, 1986, 17(2) : 270.
  • 5Caslake MJ, Packard CJ, Suckling KE, et al. Lipoprotein-ssociated hospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease [ J]. Atheroclerosis, 2000, 150(2) : 413-419.
  • 6Packard C, O'Rreilly DS, Caslake MJ, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group[J]. N Engl J Med, 2000, 343(16) :1148-1155.
  • 7Blake G J, Dada N, Fox JC, et al. A prospective evaluation of lipoprotein associated phospholipase A2 levels and the risk of future eardiovascular events in women [J ]. J Am Coll Cardiol, 2001, 38 (5) : 1302-1306.
  • 8Abuzeid AM, Hawe E, Humphries SE, et al. HIFMECH Study Group. Association between the Ala379Val variant of the lipoprotein associated phospho-lipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis, 2003, 168 : 283 -288.
  • 9Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983, 51: 606.
  • 10Natalie K, Wolfgang K. Predicting the risk of cardiovascular disease : where does lipoprotein associated phospho-lipase A2 fit in? Molecular Diagnosis & Therapy, 2007, 11: 203-217.

共引文献201

同被引文献64

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部